Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/11/3/e006617.full |
| _version_ | 1797669426055610368 |
|---|---|
| author | Lisa H Butterfield Hideho Okada Sabine Mueller Zinal S Chheda Bindu Hegde Akane Yamamichi |
| author_facet | Lisa H Butterfield Hideho Okada Sabine Mueller Zinal S Chheda Bindu Hegde Akane Yamamichi |
| author_sort | Lisa H Butterfield |
| collection | DOAJ |
| first_indexed | 2024-03-11T20:44:11Z |
| format | Article |
| id | doaj.art-2cb71781e80340c69c2ec3d388c0ada8 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T20:44:11Z |
| publishDate | 2023-03-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-2cb71781e80340c69c2ec3d388c0ada82023-10-01T19:05:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-03-0111310.1136/jitc-2022-006617Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et alLisa H Butterfield0Hideho Okada1Sabine Mueller2Zinal S Chheda3Bindu Hegde4Akane Yamamichi5Parker Institute for Cancer Immunotherapy, San Francisco, California, USADepartment of Neurosurgery, UCSF, San Francisco, California, USADepartment of Neurology, UCSF, San Francisco, California, USASanofi Genzyme, Cambridge, Massachusetts, USA3T Biosciences Inc, Palo Alto, California, USADepartment of Neurology, UCSF, San Francisco, California, USAhttps://jitc.bmj.com/content/11/3/e006617.full |
| spellingShingle | Lisa H Butterfield Hideho Okada Sabine Mueller Zinal S Chheda Bindu Hegde Akane Yamamichi Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al Journal for ImmunoTherapy of Cancer |
| title | Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al |
| title_full | Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al |
| title_fullStr | Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al |
| title_full_unstemmed | Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al |
| title_short | Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al |
| title_sort | correspondence on h3 3k27m mutation is not a suitable target for immunotherapy in hla a2 patients with diffuse midline glioma by immisch et al |
| url | https://jitc.bmj.com/content/11/3/e006617.full |
| work_keys_str_mv | AT lisahbutterfield correspondenceonh33k27mmutationisnotasuitabletargetforimmunotherapyinhlaa2patientswithdiffusemidlinegliomabyimmischetal AT hidehookada correspondenceonh33k27mmutationisnotasuitabletargetforimmunotherapyinhlaa2patientswithdiffusemidlinegliomabyimmischetal AT sabinemueller correspondenceonh33k27mmutationisnotasuitabletargetforimmunotherapyinhlaa2patientswithdiffusemidlinegliomabyimmischetal AT zinalschheda correspondenceonh33k27mmutationisnotasuitabletargetforimmunotherapyinhlaa2patientswithdiffusemidlinegliomabyimmischetal AT binduhegde correspondenceonh33k27mmutationisnotasuitabletargetforimmunotherapyinhlaa2patientswithdiffusemidlinegliomabyimmischetal AT akaneyamamichi correspondenceonh33k27mmutationisnotasuitabletargetforimmunotherapyinhlaa2patientswithdiffusemidlinegliomabyimmischetal |